Purchase Order 75N91019P00021
Award Date 10/31/18
Potential Completion Date 10/31/19
Potential Value $12K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...
- The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $18,781.20 on May 31, 2018, with an ultimate completion date of May 31, 2019. No set-aside was used. Performance takes place in Marshallton, Delaware. The order is for firm fixed price supply of analytical laboratory instruments and associated consumables from Agilent's Customer Service and Sales Division, a manufacturer of gas chromatography-mass spectrometry systems, liquid chromatography-mass...
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>
- <p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on February 7, 2014, valued at $4,075.65, with completion by February 28, 2015. Performance occurs at Marshallton, Delaware. The order carries no set-aside designation and uses firm fixed pricing.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $11,998.80 on October 29, 2019, for a maintenance agreement with an ultimate completion date of October 31, 2020. Place of performance is Marshtonlon, Delaware. The order is firm fixed price with no set-aside designation.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>
- The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,018.50 on January 31, 2018, with an ultimate completion date of January 25, 2019. The order carries fixed-price pricing with economic price adjustment and no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order procures analytical laboratory instruments and associated consumables or services, consistent with Agilent's role as a supplier of gas chromatography-mass...
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a reagent kit valued at $16,259.00 on August 26, 2019, with completion by September 18, 2019. Place of performance is Marshallton, Delaware. No set-aside was used. The order was issued on a firm fixed price basis for commercial laboratory consumables, consistent with Agilent's role as a supplier of analytical instrumentation and related supplies to federal research agencies.</p>
- <p>The National Cancer Institute issued a delivery order to Agilent Technologies Inc. on August 23, 2018, with a ceiling value of $39,684.59 for a high-pressure liquid chromatography system for separation and analyses of radiolabeled chemicals.</p> <p>Place of performance is Marshallton, Delaware. The order is firm fixed price with an ultimate completion date of October 2, 2018. No set-aside was used.</p>